A detailed history of Mc Clarren Financial Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mc Clarren Financial Advisors, Inc. holds 1,577 shares of MRK stock, worth $150,887. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,577
Previous 742 112.53%
Holding current value
$150,887
Previous $269,000 198.51%
% of portfolio
0.1%
Previous 0.19%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$111.15 - $128.97 $92,810 - $107,689
835 Added 112.53%
1,577 $803,000
Q2 2024

Jul 26, 2024

SELL
$123.8 - $132.96 $180,129 - $193,456
-1,455 Reduced 66.23%
742 $269,000
Q1 2024

Jul 26, 2024

BUY
$113.24 - $131.95 $159,102 - $185,389
1,405 Added 177.4%
2,197 $290,000
Q1 2024

May 03, 2024

SELL
$113.24 - $131.95 $157,403 - $183,410
-1,390 Reduced 63.7%
792 $290,000
Q4 2023

Feb 02, 2024

BUY
$100.18 - $109.02 $1,703 - $1,853
17 Added 0.79%
2,182 $238,000
Q3 2023

Nov 03, 2023

BUY
$102.95 - $114.33 $1,338 - $1,486
13 Added 0.6%
2,165 $222,000
Q2 2023

Aug 04, 2023

BUY
$108.61 - $118.38 $53,327 - $58,124
491 Added 29.56%
2,152 $248,000
Q1 2023

May 05, 2023

BUY
$102.94 - $114.86 $823 - $918
8 Added 0.48%
1,661 $175,000
Q4 2022

Jan 30, 2023

BUY
$87.44 - $112.11 $30,866 - $39,574
353 Added 27.15%
1,653 $183,000
Q3 2022

Oct 31, 2022

BUY
$84.53 - $94.96 $109,889 - $123,447
1,300 New
1,300 $111,000
Q2 2022

Aug 11, 2022

SELL
$83.49 - $94.64 $84,241 - $95,491
-1,009 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$73.51 - $82.4 $588 - $659
8 Added 0.8%
1,009 $81,000
Q4 2021

Jan 19, 2022

BUY
$72.28 - $90.54 $25,153 - $31,507
348 Added 53.29%
1,001 $77,000
Q3 2021

Oct 15, 2021

BUY
$71.68 - $78.83 $358 - $394
5 Added 0.77%
653 $49,000
Q2 2021

Jul 23, 2021

BUY
$70.31 - $77.77 $17,436 - $19,286
248 Added 62.0%
648 $50,000
Q4 2020

Jan 29, 2021

BUY
$71.77 - $79.65 $28,708 - $31,860
400 New
400 $32,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $242B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mc Clarren Financial Advisors, Inc. Portfolio

Follow Mc Clarren Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Clarren Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Clarren Financial Advisors, Inc. with notifications on news.